CLINICAL_TRIALS
trial_result
· 2026-01-08
Clinical Trial Update: A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity [Phase 2]
Summary
A Phase 2 clinical trial evaluating the combination of NNC0165-1875 with semaglutide for obesity has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2026-01-08